Ryan Overland
Impact in
-
- Genetic Neurodegenerative Diseases
- Nerve injury and regeneration
- Developmental Neuroscience top 10%
Papers in
-
- Glycosylation and Glycoproteins Research 4
- Ubiquitin and proteasome pathways 2
- Oncology 8
- HER2/EGFR in Cancer Research 7
- Co-authors
- Ghazaleh Sadri‐Vakili (3 shared papers)Eva Xia (3 shared papers)Violette Paragas (7 shared papers)Ulrik B. Nielsen (8 shared papers)Charlotte F. McDonagh (7 shared papers)J. Jang‐Ho (2 shared papers)Andrew D. Strand (1 shared paper)Richard G. Ellenbogen (1 shared paper)
- Journals
- Cancer Research (5 papers)Journal of Neuroscience (2 papers)Molecular Cancer Therapeutics (1 paper)Nature Medicine (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesItalySpain
In The Last Decade
Ryan Overland
12 papers receiving 823 citations
Peers
Comparison fields: 5 of 80
- Cellular and Molecular Neuroscience 245
- Developmental Neuroscience 41
- Radiology, Nuclear Medicine and Imaging 211
- Oncology 243
- Molecular Biology 556
Countries citing papers authored by Ryan Overland
This map shows the geographic impact of Ryan Overland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Overland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Overland more than expected).
Fields of papers citing papers by Ryan Overland
This network shows the impact of papers produced by Ryan Overland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Overland. The network helps show where Ryan Overland may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryan Overland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 222 | |
| 2 | 2007 | 170 | |
| 3 | 2003 | 156 | |
| 4 | 2010 | 135 | |
| 5 | 2013 | 85 | |
| 6 | 2008 | 50 | |
| 7 | 2013 | 9 | |
| 8 | 2009 | 6 | |
| 9 | 2010 | 4 | |
| 10 | 2013 | 3 | |
| 11 | 2011 | 1 | |
| 12 | 2011 | 1 |
About Ryan Overland
Ryan Overland is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Cellular and Molecular Neuroscience and Pulmonary and Respiratory Medicine, having authored 12 papers that have together received 842 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (4 papers), Lung Cancer Treatments and Mutations (2 papers), Genetic Neurodegenerative Diseases (2 papers), Ubiquitin and proteasome pathways (2 papers), Neurogenesis and neuroplasticity mechanisms (1 paper) and Nerve injury and regeneration (1 paper). The work is most often cited by research in Cellular and Molecular Neuroscience (245 citations), Developmental Neuroscience (41 citations), Radiology, Nuclear Medicine and Imaging (211 citations), Oncology (243 citations) and Molecular Biology (556 citations). Ryan Overland has collaborated with scholars based in United States, Italy and Spain. Frequent co-authors include Ghazaleh Sadri‐Vakili, Eva Xia, Violette Paragas, Ulrik B. Nielsen, Charlotte F. McDonagh, J. Jang‐Ho, Andrew D. Strand, Richard G. Ellenbogen, Roshantha A.S. Chandraratna and Joel I. Pritchard. Their work appears in journals such as Cancer Research, Journal of Neuroscience, Molecular Cancer Therapeutics, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.